Melanoma Epidemiology and Prevention

Marianne Berwick(University of New Mexico), Sarah V. Ward(University of Western Australia), Nancy E. Thomas(University of North Carolina at Chapel Hill), Richard P. Gallagher(BC Cancer Agency), Frank L. Meyskens(University of California, Irvine), Shaily Pandey(Icahn School of Medicine at Mount Sinai), David B. Buller(Klein Buendel (United States)), Anne Ε. Cust(The University of Sydney), Tim K. Lee(BC Cancer Agency), Marit B. Veierød
Cancer treatment and research
November 24, 2015
10.1007/978-3-319-22539-5_2
Cited by 148

Related Papers

Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040
|JAMA Dermatology|2022|1.4k
A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma
|Nature|2011|474
Clinical Oncology Society of Australia position statement on exercise in cancer care
|The Medical Journal of Australia|2018|443
Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development.
|PubMed|2002|383
Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium
|The Lancet Oncology|2005|378